Michael Rosu‐Myles

1.9k total citations
48 papers, 1.4k citations indexed

About

Michael Rosu‐Myles is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Michael Rosu‐Myles has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Genetics and 14 papers in Hematology. Recurrent topics in Michael Rosu‐Myles's work include Mesenchymal stem cell research (15 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Immunotherapy and Immune Responses (8 papers). Michael Rosu‐Myles is often cited by papers focused on Mesenchymal stem cell research (15 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Immunotherapy and Immune Responses (8 papers). Michael Rosu‐Myles collaborates with scholars based in Canada, Spain and United States. Michael Rosu‐Myles's co-authors include Jessie R. Lavoie, Pablo Menéndez, René Rodrı́guez, Mickie Bhatia, Linda Wolff, David Allan, Ruth Rubio, Simon Sauvé, Mitchell Sabloff and Xuguang Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Michael Rosu‐Myles

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Rosu‐Myles Canada	23	704	401	322	319	262	48	1.4k
Alexis S. Bailey United States	14	875 1.2×	374 0.9×	339 1.1×	211 0.7×	240 0.9×	17	1.6k
Aiko Sato‐Otsubo Japan	20	860 1.2×	231 0.6×	188 0.6×	494 1.5×	352 1.3×	40	1.6k
Stephen Fitter Australia	24	709 1.0×	317 0.8×	339 1.1×	644 2.0×	201 0.8×	39	1.8k
François Mercier Canada	16	1.1k 1.5×	325 0.8×	311 1.0×	642 2.0×	533 2.0×	51	2.1k
Jane Reese United States	19	658 0.9×	316 0.8×	340 1.1×	144 0.5×	134 0.5×	52	1.1k
Robert Pawliuk United States	20	1.6k 2.3×	471 1.2×	353 1.1×	341 1.1×	208 0.8×	25	2.4k
Gustavo J. Melen Spain	22	746 1.1×	216 0.5×	237 0.7×	186 0.6×	86 0.3×	40	1.3k
Kendra L. Congdon United States	14	999 1.4×	417 1.0×	614 1.9×	305 1.0×	718 2.7×	25	1.9k
Suzan Imren United States	20	769 1.1×	256 0.6×	420 1.3×	429 1.3×	172 0.7×	43	1.5k
Selim Kuçi Germany	28	569 0.8×	650 1.6×	621 1.9×	581 1.8×	629 2.4×	53	2.0k

Countries citing papers authored by Michael Rosu‐Myles

Since Specialization

Citations

This map shows the geographic impact of Michael Rosu‐Myles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rosu‐Myles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rosu‐Myles more than expected).

Fields of papers citing papers by Michael Rosu‐Myles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rosu‐Myles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rosu‐Myles. The network helps show where Michael Rosu‐Myles may publish in the future.

Co-authorship network of co-authors of Michael Rosu‐Myles

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rosu‐Myles. A scholar is included among the top collaborators of Michael Rosu‐Myles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rosu‐Myles. Michael Rosu‐Myles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pfeifle, Annabelle, Sathya N. Thulasi Raman, Jian Wu, et al.. (2023). DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice. Frontiers in Immunology. 14. 1020134–1020134. 17 indexed citations

Gravel, Caroline, Greg Harris, Anwar M. Hashem, et al.. (2022). Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice. Human Vaccines & Immunotherapeutics. 18(5). 2083428–2083428. 5 indexed citations

Muradia, Gauri, Christian Luebbert, Michael Johnston, et al.. (2021). Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell. Stem Cell Research & Therapy. 12(1). 127–127. 82 indexed citations

Russell, Marsha S., Sathya N. Thulasi Raman, Caroline Gravel, et al.. (2021). Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats. Frontiers in Immunology. 12. 747866–747866. 7 indexed citations

Gravel, Caroline, Annabelle Pfeifle, Anwar M. Hashem, et al.. (2021). Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages. iScience. 24(11). 103328–103328. 7 indexed citations

Muradia, Gauri, Christian Luebbert, David Allan, et al.. (2019). A comprehensive proteomics profiling identifies NRP1 as a novel identity marker of human bone marrow mesenchymal stromal cell-derived small extracellular vesicles. Stem Cell Research & Therapy. 10(1). 401–401. 24 indexed citations

Russell, Marsha S., Changgui Li, Jun Gao, et al.. (2019). Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine. Frontiers in Immunology. 10. 597–597. 9 indexed citations

Russell, Marsha S., Caroline Gravel, Changgui Li, et al.. (2018). Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection. Scientific Reports. 8(1). 16648–16648. 6 indexed citations

Guardia, Rafael Díaz de la, Belén López‐Millán, Jessie R. Lavoie, et al.. (2017). Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes. Stem Cell Reports. 8(6). 1573–1586. 75 indexed citations

10.

López‐Millán, Belén, Rafael Díaz de la Guardia, Heleia Roca-Ho, et al.. (2017). Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease. Experimental & Molecular Medicine. 49(2). e290–e290. 19 indexed citations

11.

Cook, Matthew, Sherif J. Kaldas, Gauri Muradia, Michael Rosu‐Myles, & Jeremy P. Kunkel. (2015). Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody. Journal of Chromatography B. 997. 162–178. 20 indexed citations

12.

Le, Yevgeniya, et al.. (2015). Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors. Leukemia Research. 39(4). 486–493. 58 indexed citations

13.

Rodrı́guez, René, Michael Rosu‐Myles, Marcos J. Araúzo‐Bravo, et al.. (2014). Human Bone Marrow Stromal Cells Lose Immunosuppressive and Anti-inflammatory Properties upon Oncogenic Transformation. Stem Cell Reports. 3(4). 606–619. 33 indexed citations

14.

Menéndez, Pablo, René Rodrı́guez, Mario Delgado, & Michael Rosu‐Myles. (2014). Human bone marrow mesenchymal stem cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation. Experimental Hematology. 42(8). S49–S49. 3 indexed citations

15.

Rosu‐Myles, Michael, et al.. (2013). The Globoseries Glycosphingolipid SSEA-4 Is a Marker of Bone Marrow-Derived Clonal Multipotent Stromal Cells In Vitro and In Vivo. Stem Cells and Development. 22(9). 1387–1397. 22 indexed citations

16.

Humeniuk, Rita, Michael Rosu‐Myles, Joanna Fares, et al.. (2013). The role of tumor suppressor p15Ink4b in the regulation of hematopoietic progenitor cell fate. Blood Cancer Journal. 3(1). e99–e99. 13 indexed citations

17.

Lavoie, Jessie R. & Michael Rosu‐Myles. (2013). Uncovering the secretes of mesenchymal stem cells. Biochimie. 95(12). 2212–2221. 148 indexed citations

18.

Hashem, Anwar M., Caroline Gravel, Tracey M. Doyle, et al.. (2012). Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge. Human Vaccines & Immunotherapeutics. 8(4). 425–430. 16 indexed citations

19.

Boulanger, Corinne A., Robert D. Bruno, Michael Rosu‐Myles, & Gilbert H. Smith. (2011). The Mouse Mammary Microenvironment Redirects Mesoderm-Derived Bone Marrow Cells to a Mammary Epithelial Progenitor Cell Fate. Stem Cells and Development. 21(6). 948–954. 35 indexed citations

20.

Rosu‐Myles, Michael, Barbara J. Taylor, & Linda Wolff. (2007). Loss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitors. Experimental Hematology. 35(3). 394–406. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact